FTC keeps Medco deal under observation
The pharmaceutical business faces a new US merger (Credit: Wikimedia Commons)
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now